Information Provided By: 
Fly News Breaks for August 20, 2015
ESRX
Aug 20, 2015 | 09:20 EDT
Cleveland Research said manufacturers are paying higher and higher levels of rebates back to PBMs. The firm is hearing Express Script's total rebate value is in the $2B-$2.5B range, up from $1.2B last year. Cleveland said higher rebates will help Express Scripts improve its ability to manage drug trends for their clients and become increasingly more competitive with pricing. The firm has a Neutral rating on shares.
News For ESRX From the Last 2 Days
There are no results for your query ESRX
